跳至主要内容
临床试验/NCT03266107
NCT03266107已完成不适用

A Prospective, Open-Label, Single-Arm Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain

Relievant Medsystems, Inc.4 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年2月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
4
主要终点
Oswestry Disability Index (ODI) - 3 Months

研究概览

简要总结

Prospective, single arm, open label, multi-center study to evaluated the effectiveness of intraosseous basivertebral nerve radiofrequency ablation using the Intracept System.

详细描述

This is a prospective, open-label, single-arm study of patients diagnosed with vertebrogenic low back pain for a minimum of 6 months with conservative care. Participants will receive the Intracept System procedure to ablate the basivertebral nerve within the vertebral body. Treatment is performed on all vertebral bodies with Modic type 1 or type 2 changes on MRI from L3-S1.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Skeletally mature subjects at least 25 years of age
  • Chronic low back pain for at least 6 months
  • Failure to respond to at least 6 months of non-operative conservative management
  • Oswestry Disability Index (ODI) at least 30 points
  • Modic changes Type 1 or 2

排除标准

  • Current or history of vertebral cancer or spinal metastasis
  • History of a fragility fracture
  • Any back pathology related to trauma, evidence of vertebral compression fracture or other spinal pathology that could affect assessment of response to back pain
  • Disc extrusion or protrusion

结局指标

主要结局

Oswestry Disability Index (ODI) - 3 Months

时间窗: 3 months

Change in mean Oswestry Disability Index (ODI) total score from baseline to 3 months post-treatment. ODI total score scale of 0 (no disability) to 100 (complete disability), with categories of 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The minimally clinically important difference in ODI from baseline is considered to be a 10 points reduction from baseline.

次要结局

  • VAS - 12 Month(12 Months)
  • ODI Responder Rate - 12-Month(12 Months)
  • ODI Responder Rate - 3-Month(3 Months)
  • VAS Responder Rate - 12 Months(12 Months)
  • Visual Analog Scale (VAS) - 3 Months(3 Months)
  • VAS Reduction 50% or More - 12 Month(12 Months)
  • VAS Responder Rate - 3 Month(3 Months)
  • ODI -12 Months(12 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验